1. Home
  2. NEPH vs UG Comparison

NEPH vs UG Comparison

Compare NEPH & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • UG
  • Stock Information
  • Founded
  • NEPH 1997
  • UG 1942
  • Country
  • NEPH United States
  • UG United States
  • Employees
  • NEPH N/A
  • UG N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • UG Package Goods/Cosmetics
  • Sector
  • NEPH Health Care
  • UG Consumer Discretionary
  • Exchange
  • NEPH Nasdaq
  • UG Nasdaq
  • Market Cap
  • NEPH 45.3M
  • UG 36.4M
  • IPO Year
  • NEPH 2004
  • UG N/A
  • Fundamental
  • Price
  • NEPH $5.71
  • UG $7.53
  • Analyst Decision
  • NEPH Strong Buy
  • UG
  • Analyst Count
  • NEPH 2
  • UG 0
  • Target Price
  • NEPH $5.50
  • UG N/A
  • AVG Volume (30 Days)
  • NEPH 66.1K
  • UG 6.9K
  • Earning Date
  • NEPH 11-06-2025
  • UG 11-07-2025
  • Dividend Yield
  • NEPH N/A
  • UG 9.21%
  • EPS Growth
  • NEPH N/A
  • UG N/A
  • EPS
  • NEPH 0.12
  • UG 0.56
  • Revenue
  • NEPH $16,684,000.00
  • UG $10,856,174.00
  • Revenue This Year
  • NEPH $24.38
  • UG N/A
  • Revenue Next Year
  • NEPH $10.16
  • UG N/A
  • P/E Ratio
  • NEPH $47.49
  • UG $13.58
  • Revenue Growth
  • NEPH 21.16
  • UG N/A
  • 52 Week Low
  • NEPH $1.36
  • UG $7.50
  • 52 Week High
  • NEPH $5.94
  • UG $15.05
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 76.00
  • UG 41.08
  • Support Level
  • NEPH $4.52
  • UG $7.50
  • Resistance Level
  • NEPH $4.89
  • UG $8.09
  • Average True Range (ATR)
  • NEPH 0.34
  • UG 0.25
  • MACD
  • NEPH 0.12
  • UG -0.03
  • Stochastic Oscillator
  • NEPH 87.01
  • UG 3.47

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: